Pricing Log in Create free account

NuCana PLC Sponsored ADR (NCNA) vs Xenetic Biosciences, Inc. (XBIO)

NuCana PLC Sponsored ADR and Xenetic Biosciences, Inc. are both Biotechnology companies. NuCana PLC Sponsored ADR and Xenetic Biosciences, Inc. are of similar size ($4.7M and $4.4M). NuCana PLC Sponsored ADR has the higher net margin (0.00% vs −75.9%) and the lower return on invested capital (−1,130.2% vs 0.00%). Across the 14 metrics below, Xenetic Biosciences, Inc. leads on 8 and NuCana PLC Sponsored ADR on 6.

Valuation

Metric NCNA XBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.39 9.71
P/B 0.00 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.45 0.30 0.64
EV/Sales n/m (0.24) 9.21
Earnings yield (226,311.31%) (58.59%) (33.15%)
Free cash flow yield (170,262.15%) (50.87%) (25.50%)

Profitability

Metric NCNA XBIO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (68.70%) (47.05%) (56.36%)
Return on assets (45.24%) (40.17%) (48.04%)
Return on invested capital (1,130.23%) 0.00% 0.00%

Growth

Metric NCNA XBIO Biotechnology median
Revenue growth (TTM) — 33.30% 6.02%
EPS growth (last fiscal year) 98.96% 38.52% 30.26%
Revenue growth, 5-year CAGR — 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NCNA XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.73 7.43 4.72
Net debt to EBITDA 1.23 2.78 0.96

Dividend

Metric NCNA XBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NCNA XBIO Biotechnology median
Market cap 4.40m 4.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack